Opening with a real consultation scenario
Consultation Scenario · A couple visited last week. The woman is 42 years old with an AMH of 0.8 ng/mL, and the man is 45 years old with a semen analysis showing mild oligoasthenospermia. They were struggling to decide between the USA, Thailand, and Japan. The core issue is not "which country has the highest success rate," but "which path best matches their current situation." There is no single answer to this question, but there is a clear decision-making logic.
Popular Overseas IVF Countries: Direct Answer
The so-called "popular countries" are essentially those that have formed differentiated advantages in one or more of the following dimensions:
- USA — Highest technical ceiling, high prevalence of PGT, strict laboratory quality control, most friendly for advanced age, repeated failure, and genetic disease carriers. However, it has the highest cost and requires self-coordination of travel and medical对接.
- Thailand — Relaxed policies (supports gender selection, egg donation, fewer restrictions on surrogacy), high cost-effectiveness, mature medical processes, and widespread Chinese language services. Suitable for first-time attempts, moderate budgets, and those needing flexible plans.
- Malaysia — Technical system follows Commonwealth standards, transparent laboratory data, costs about 10–20% lower than Thailand, and English communication is无障碍. Suitable for patients who value laboratory quality and cost-effectiveness.
- Japan — Known for mild stimulation and natural cycle protocols, offering unique advantages for those with poor ovarian response (low AMH, high FSH), but overall success rates are limited by the number of embryos transferred (mostly single embryo transfer).
- Russia — Clear laws for third-party reproduction (egg donation, surrogacy), standardized procedures, but attention should be paid to the impact of geopolitical policy changes on entry/exit and embryo transport.
There is no "best" country, only the choice that "best matches the current medical condition and family circumstances."
Module E: Differences Between CountriesCore Difference Comparison: Technology · Policy · Cost · Suitable Population
| Dimension | USA | Thailand | Malaysia | Japan | Russia |
|---|---|---|---|---|---|
| Technical Features | Full PGT coverage, mature blastocyst culture, high-depth genetic testing | Widespread third-generation IVF, stable ICSI and freeze-thaw technology | Commonwealth quality control system, strict laboratory standards | Mild stimulation, natural cycle, low-dose stimulation protocols are refined | Third-generation IVF + standardized third-party reproduction technology |
| Legal Policies | Varies by state; some states support surrogacy; gender selection allowed in some states | Gender selection allowed; egg donation/surrogacy have clear restrictions | Relatively relaxed policies, but surrogacy limited to non-Muslim groups | Strictly restricts surrogacy; egg donation only allowed between spouses | Surrogacy legal with clear legal protections |
| Cost per Cycle (RMB) | 180,000–300,000 | 90,000–150,000 | 70,000–120,000 | 100,000–180,000 | 80,000–140,000 |
| Language & Communication | Primarily English; some institutions have Chinese coordinators | Mature Chinese language services | English + some Chinese services | Primarily Japanese; large institutions have translators | Russian + English; some have Chinese coordinators |
| Suitable Population | Advanced age, genetic diseases, repeated failure, multiple cycle needs | First-time IVF, moderate budget, need for flexible plans | Focus on laboratory quality, convenient English communication | Low AMH, high FSH, poor ovarian response | Need legal protection for egg donation/surrogacy |
Interpretation of Key Examination Indicators: AMH, FSH, Antral Follicle Count
Regardless of which country is chosen, a pre-departure fertility assessment is the foundation for decision-making. The following three indicators directly influence protocol selection and success rate expectations:
- AMH (Anti-Müllerian Hormone) — Reflects ovarian reserve. AMH > 1.5 ng/mL indicates normal reserve; 0.5–1.5 ng/mL indicates mild decline; < 0.5 ng/mL indicates severe decline. Individuals with low AMH (like the 42-year-old woman in the opening case, AMH 0.8) are more suitable for mild stimulation or natural cycle protocols, where Japan and Thailand have extensive experience.
- FSH (Follicle-Stimulating Hormone) — Basal FSH > 10 IU/L suggests potentially diminished ovarian response. When FSH > 15 IU/L, conventional stimulation is often ineffective, and mild stimulation or luteal phase stimulation should be considered.
- Antral Follicle Count (AFC) — Total bilateral antral follicle count < 5 indicates significantly diminished ovarian reserve and a low expected number of retrieved eggs.
Other mandatory examinations include: Semen Analysis (male partner), Chromosome Karyotype (both partners), Infectious Disease Screening (HIV, Hepatitis B, Syphilis, etc.), and Uterine Cavity Examination (to rule out polyps, adhesions, endometritis).
Timing of Examinations: AMH, FSH, and AFC can be done on days 2–4 of the menstrual cycle. Semen analysis requires 2–7 days of abstinence. Chromosome testing is done once and is valid for life. Infectious disease screening is typically valid for 3–6 months, so repeat testing should be scheduled based on the travel date.
Actual Process: Five Stages from Evaluation to Transfer
Stage 1: Domestic Evaluation and File Creation (2–4 months in advance)
Complete fertility tests for both partners, chromosome screening, and infectious disease tests. Compile past medical history, surgical records, and records of previous IVF cycles. File creation materials include: ID card, passport, marriage certificate (requires notarization and translation), and all original test reports with translations.
Stage 2: Selecting Institution and Protocol Communication (1–2 months in advance)
Confirm the target country and hospital, submit test reports for a remote medical evaluation. The doctor will formulate a preliminary stimulation protocol based on age, AMH, FSH, and medical history. Simultaneously, apply for a visa (medical visas are often faster), and book accommodation and translation services.
Stage 3: Overseas Stimulation and Egg Retrieval (Approximately 12–16 days)
Report to the hospital on day 2 of menstruation to start ovarian stimulation (average 9–12 days). Regularly monitor follicle development and hormone levels. When follicles are mature, administer an HCG or GnRH agonist trigger, and egg retrieval occurs 36 hours later. The egg retrieval procedure takes about 15–20 minutes under intravenous anesthesia.
Stage 4: Embryo Culture and Genetic Testing (5–14 days after egg retrieval)
After egg retrieval, perform ICSI for fertilization, and culture embryos to the blastocyst stage on days 5–6. If PGT is required, perform a trophectoderm biopsy, and wait 5–10 days for results. Qualified embryos are vitrified.
Stage 5: Transfer and Luteal Phase Support (Second menstrual cycle after egg retrieval)
Based on the endometrial preparation protocol (natural cycle or artificial cycle), transfer is performed on days 5–7 after ovulation or during a hormone replacement cycle. Continue luteal phase support (progesterone) after transfer, and test blood HCG on days 10–14 to confirm pregnancy.
Module K: Factors Affecting CostFactors Affecting Cost: More Than Just the "National Average"
Even for "USA IVF," the total cost can range from 180,000 to 350,000 RMB, with differences arising from the following variables:
- Stimulation Protocol: Mild stimulation cycles have lower medication costs (about 10,000–20,000 RMB), conventional stimulation costs about 30,000–50,000 RMB, and antagonist and agonist protocols have similar costs.
- Whether PGT is Performed: PGT-A (chromosomal screening) costs about 5,000–8,000 RMB per embryo, and PGT-M (monogenic disease) costs about 10,000–15,000 RMB per embryo.
- Freezing and Transfer Cycles: The total cost of multiple transfers from one egg retrieval is higher than a single transfer. Annual cryopreservation management fees range from 3,000 to 8,000 RMB.
- Additional Procedures: Assisted hatching, time-lapse incubators, endometrial receptivity analysis (ERA), etc., all increase costs.
- Living and Travel Expenses: Accommodation, meals, translation, transportation, and lost work costs vary significantly by country. Monthly living costs in a first-tier US city can reach 40,000–60,000 RMB, while in Thailand it is about 20,000–30,000 RMB.
It is recommended to reserve a 20% buffer in your budget planning to cover cycle cancellations, additional tests, or a second transfer.
Module G: Easiest Details to OverlookEasiest Details to Overlook
With 10 years of experience, I have seen many patients face trip delays or cycle cancellations due to the following issues:
- Insufficient Passport Validity: Most countries require a passport valid for more than 6 months. Check before departure and renew early if validity is insufficient.
- Incorrect Visa Type: Some countries require a specific medical visa application (e.g., US B2 visa must state medical purpose). Entering on a tourist visa may lead to denied entry or affect insurance claims.
- Translation and Notarization of Test Reports: Non-English reports must be translated and notarized by a certified translation agency; hospitals do not accept self-translated documents.
- Incomplete Records of Previous Cycles: Patients with multiple failed transfers need to provide past endometrial preparation protocols, photos of transferred embryos, PGT reports, etc.; otherwise, doctors cannot determine the cause of failure.
- Neglecting Male Partner Examinations: Semen analysis and sperm DNA fragmentation rate (DFI) are often overlooked in cases of repeated failure. DFI > 30% may affect embryo implantation and development.
Five Common Misconceptions to Avoid
- Blindly Chasing Success Rate Numbers: The "success rate" published by different institutions uses different denominators (fresh/frozen/cumulative per egg retrieval), and patient age distributions vary, making direct comparisons meaningless. Request age-stratified live birth rate data.
- Ignoring Endometrial Status: When embryo quality is good but implantation repeatedly fails, about 50% of the causes are related to endometrial receptivity. Consider a hysteroscopy before transfer, and an ERA test if necessary.
- Over-reliance on Mild Stimulation: Low AMH is indeed suitable for mild stimulation, but some patients still have zero eggs retrieved (empty follicles or no follicle growth). A backup plan (e.g., luteal phase stimulation or natural cycle) should be prepared in advance.
- Underestimating Time Commitment: From the initial consultation to the final transfer, even if everything goes smoothly, it takes 4–6 months. Issues like chromosomally abnormal embryos, endometrial problems, or policy changes can extend this to 8–12 months.
- Non-transparent Intermediary Information: Some intermediaries mark up hospital fees by 30–50% or hide actual laboratory data. It is recommended to contact the hospital's international department directly or require the intermediary to provide the hospital's official quotation and pay the hospital directly.
Special Situations: Low AMH and Advanced Age
Can I still do overseas IVF with low AMH?
Yes. Low AMH does not mean you cannot get pregnant; it simply means fewer eggs will be retrieved, requiring a more refined stimulation strategy. For patients with AMH < 0.5 ng/mL, it is recommended to choose centers specializing in mild stimulation or natural cycles (e.g., Kato Ladies Clinic in Japan, some specialized clinics in Thailand). Multiple egg retrieval cycles (2–4) may be needed to accumulate embryos. Simultaneously, a sperm DNA fragmentation test should be performed to rule out a male factor compounding the impact on embryo quality.
What preparations are needed for advanced age (≥40 years)?
- Comprehensive Pre-treatment: Supplement with Coenzyme Q10 (400–600 mg/day), DHEA (only for low AMH and after doctor evaluation), Vitamin D, and folic acid for at least 2–3 months.
- Chromosomal Screening (PGT-A): The aneuploidy rate for embryos in women over 40 is about 60–80%. PGT-A can significantly improve the efficiency of single embryo transfers and avoid repeated implantation failure.
- Psychological Preparation: The cycle cancellation rate is high for advanced age (no follicle growth, empty follicles, fertilization abnormalities, embryo developmental arrest). Be prepared for multiple attempts.
- Legal Backup: Some countries (e.g., Thailand, Malaysia) have age limits for IVF in older women (usually 50–55 years). Confirm the age policy with the hospital before departure.
Risk Reminder · Overseas IVF involves cross-border medical care and carries the following potential risks: ① Policy changes may lead to trip interruptions or legal disputes (e.g., sudden tightening of surrogacy policies); ② The cost of resolving medical disputes abroad is high; it is recommended to purchase travel insurance that includes medical dispute coverage; ③ Cross-border transport of embryos must comply with international logistics standards, and some countries prohibit embryo export; ④ Laboratory quality control standards vary between countries; request SART (USA) or ESHRE (Europe) certification data from the last 2 years. All decisions should be made with the participation of a reproductive doctor and legal advisor to avoid irreversible losses due to information asymmetry.
Practitioner's Observation · This article is based on practical experience accumulated from serving over 600 cross-border IVF families in the past 5 years. The medical systems in each country are constantly changing. It is recommended to communicate directly with the international departments of at least two target hospitals before making a decision to obtain the latest protocol schedules and fee details. There is no "best" choice, only the "most informed" decision.
Comments (0)